Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Mechanisms of Disease and Translational Research, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia; and.
FASEB J. 2019 Feb;33(2):2719-2731. doi: 10.1096/fj.201800787R. Epub 2018 Oct 10.
Remodeling of the gut microbiota is implicated in various metabolic and inflammatory diseases of the gastrointestinal tract. We hypothesized that the gut microbiota affects the DNA methylation profile of intestinal epithelial cells (IECs) which could, in turn, alter intestinal function. In this study, we used mass spectrometry and methylated DNA capture to respectively investigate global and genome-wide DNA methylation of intestinal epithelial cells from germ-free (GF) and conventionally raised mice. In colonic IECs from GF mice, DNA was markedly hypermethylated. This was associated with a dramatic loss of ten-eleven-translocation activity, a lower DNA methyltransferase activity and lower circulating levels of the 1-carbon metabolite, folate. At the gene level, we found an enrichment for differentially methylated regions proximal to genes regulating the cytotoxicity of NK cells (false-discovery rate < 8.9E), notably genes regulating the cross-talk between NK cells and target cells, such as members of the NK group 2 member D ligand superfamily Raet. This distinct epigenetic signature was associated with a marked decrease in Raet1 expression and a loss of CD56/CD45 cells in the intestine of GF mice. Thus, our results indicate that altered activity of methylation-modifying enzymes in GF mice influences the IEC epigenome and modulates the crosstalk between IECs and NK cells. Epigenetic reprogramming of IECs may modulate intestinal function in diseases associated with altered gut microbiota.-Poupeau, A., Garde, C., Sulek, K., Citirikkaya, K., Treebak, J. T., Arumugam, M., Simar, D., Olofsson, L. E., Bäckhed, F., Barrès, R. Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice.
肠道微生物群的重塑与胃肠道的各种代谢和炎症性疾病有关。我们假设肠道微生物群会影响肠道上皮细胞(IEC)的 DNA 甲基化谱,进而改变肠道功能。在这项研究中,我们使用质谱法和甲基化 DNA 捕获法分别研究了无菌(GF)和常规饲养的小鼠的肠道上皮细胞的全基因组和全基因组 DNA 甲基化。在 GF 小鼠的结肠 IEC 中,DNA 明显超甲基化。这与十 - 十一易位活性的显著丧失、DNA 甲基转移酶活性降低以及循环 1 碳代谢物叶酸水平降低有关。在基因水平上,我们发现了靠近调节 NK 细胞细胞毒性的基因的差异甲基化区域的富集(错误发现率<8.9E),特别是调节 NK 细胞与靶细胞之间相互作用的基因,如 NK 组 2 成员 D 配体超家族 Raet 的成员。这种独特的表观遗传特征与 GF 小鼠肠道中 Raet1 表达的明显下降和 CD56/CD45 细胞的丧失有关。因此,我们的结果表明,GF 小鼠中甲基化修饰酶活性的改变会影响 IEC 的表观基因组,并调节 IEC 和 NK 细胞之间的串扰。IEC 的表观遗传重编程可能会调节与肠道微生物群改变相关的疾病中的肠道功能。-Poupeau, A., Garde, C., Sulek, K., Citirikkaya, K., Treebak, J. T., Arumugam, M., Simar, D., Olofsson, L. E., Bäckhed, F., Barrès, R. 控制自然杀伤淋巴细胞激活的基因在无菌小鼠的肠道细胞中被表观遗传重塑。